Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 33

1.

Culturing Mouse Cardiac Valves in the Miniature Tissue Culture System.

Kruithof BP, Lieber SC, Kruithof-de Julio M, Gaussin V, Goumans MJ.

J Vis Exp. 2015 Oct 19;(105):e52750. doi: 10.3791/52750.

2.

Relationships between melanocytes, mechanical properties and extracellular matrix composition in mouse heart valves.

Carneiro F, Kruithof BP, Balani K, Agarwal A, Gaussin V, Kos L.

J Long Term Eff Med Implants. 2015;25(1-2):17-26.

PMID:
25955004
3.

Remodeling of the myocardium in early trabeculation and cardiac valve formation; a role for TGFβ2.

Kruithof BP, Kruithof-De-Julio M, Poelmann RE, Gittenberger-De-Groot AC, Gaussin V, Goumans MJ.

Int J Dev Biol. 2013;57(11-12):853-63. doi: 10.1387/ijdb.130302bk.

4.

An in vivo map of bone morphogenetic protein 2 post-transcriptional repression in the heart.

Kruithof BP, Xu J, Fritz DT, Cabral CS, Gaussin V, Rogers MB.

Genesis. 2011 Nov;49(11):841-50. doi: 10.1002/dvg.20757. Epub 2011 Oct 14.

5.

An autonomous BMP2 regulatory element in mesenchymal cells.

Kruithof BP, Fritz DT, Liu Y, Garsetti DE, Frank DB, Pregizer SK, Gaussin V, Mortlock DP, Rogers MB.

J Cell Biochem. 2011 Feb;112(2):666-74. doi: 10.1002/jcb.22975.

6.

Guided cardiopoiesis enhances therapeutic benefit of bone marrow human mesenchymal stem cells in chronic myocardial infarction.

Behfar A, Yamada S, Crespo-Diaz R, Nesbitt JJ, Rowe LA, Perez-Terzic C, Gaussin V, Homsy C, Bartunek J, Terzic A.

J Am Coll Cardiol. 2010 Aug 24;56(9):721-34. doi: 10.1016/j.jacc.2010.03.066.

7.

Design of a miniature tissue culture system to culture mouse heart valves.

Lieber SC, Kruithof BP, Aubry N, Vatner SF, Gaussin V.

Ann Biomed Eng. 2010 Mar;38(3):674-82. doi: 10.1007/s10439-010-9922-8. Epub 2010 Jan 23.

8.

Apoptosis predominates in nonmyocytes in heart failure.

Park M, Shen YT, Gaussin V, Heyndrickx GR, Bartunek J, Resuello RR, Natividad FF, Kitsis RN, Vatner DE, Vatner SF.

Am J Physiol Heart Circ Physiol. 2009 Aug;297(2):H785-91. doi: 10.1152/ajpheart.00310.2009. Epub 2009 May 22.

9.

Activation of the bone morphogenetic protein receptor by H11kinase/Hsp22 promotes cardiac cell growth and survival.

Sui X, Li D, Qiu H, Gaussin V, Depre C.

Circ Res. 2009 Apr 10;104(7):887-95. doi: 10.1161/CIRCRESAHA.108.192328. Epub 2009 Feb 26.

PMID:
19246680
10.

Abnormal conduction and morphology in the atrioventricular node of mice with atrioventricular canal targeted deletion of Alk3/Bmpr1a receptor.

Stroud DM, Gaussin V, Burch JB, Yu C, Mishina Y, Schneider MD, Fishman GI, Morley GE.

Circulation. 2007 Nov 27;116(22):2535-43. Epub 2007 Nov 12.

11.
12.

H11 kinase prevents myocardial infarction by preemptive preconditioning of the heart.

Depre C, Wang L, Sui X, Qiu H, Hong C, Hedhli N, Ginion A, Shah A, Pelat M, Bertrand L, Wagner T, Gaussin V, Vatner SF.

Circ Res. 2006 Feb 3;98(2):280-8. Epub 2005 Dec 22.

PMID:
16373598
13.

Myostatin, the cardiac chalone of insulin-like growth factor-1.

Gaussin V, Depre C.

Cardiovasc Res. 2005 Dec 1;68(3):347-9. Epub 2005 Oct 13. No abstract available.

PMID:
16226233
14.

Alk3/Bmpr1a receptor is required for development of the atrioventricular canal into valves and annulus fibrosus.

Gaussin V, Morley GE, Cox L, Zwijsen A, Vance KM, Emile L, Tian Y, Liu J, Hong C, Myers D, Conway SJ, Depre C, Mishina Y, Behringer RR, Hanks MC, Schneider MD, Huylebroeck D, Fishman GI, Burch JB, Vatner SF.

Circ Res. 2005 Aug 5;97(3):219-26. Epub 2005 Jul 21.

15.

Offbeat mice.

Gaussin V.

Anat Rec A Discov Mol Cell Evol Biol. 2004 Oct;280(2):1022-6. Review.

16.

Program of cell survival underlying human and experimental hibernating myocardium.

Depre C, Kim SJ, John AS, Huang Y, Rimoldi OE, Pepper JR, Dreyfus GD, Gaussin V, Pennell DJ, Vatner DE, Camici PG, Vatner SF.

Circ Res. 2004 Aug 20;95(4):433-40. Epub 2004 Jul 8.

PMID:
15242971
17.

Common genomic response in different mouse models of beta-adrenergic-induced cardiomyopathy.

Gaussin V, Tomlinson JE, Depre C, Engelhardt S, Antos CL, Takagi G, Hein L, Topper JN, Liggett SB, Olson EN, Lohse MJ, Vatner SF, Vatner DE.

Circulation. 2003 Dec 9;108(23):2926-33. Epub 2003 Nov 17.

PMID:
14623810
18.

Cardiac progenitor cells from adult myocardium: homing, differentiation, and fusion after infarction.

Oh H, Bradfute SB, Gallardo TD, Nakamura T, Gaussin V, Mishina Y, Pocius J, Michael LH, Behringer RR, Garry DJ, Entman ML, Schneider MD.

Proc Natl Acad Sci U S A. 2003 Oct 14;100(21):12313-8. Epub 2003 Oct 6.

19.

Characterization of pDJA1, a cardiac-specific chaperone found by genomic profiling of the post-ischemic swine heart.

Depre C, Wang L, Tomlinson JE, Gaussin V, Abdellatif M, Topper JN, Vatner SF.

Cardiovasc Res. 2003 Apr 1;58(1):126-35.

PMID:
12667953
20.

Tempting fate: BMP signals for cardiac morphogenesis.

Schneider MD, Gaussin V, Lyons KM.

Cytokine Growth Factor Rev. 2003 Feb;14(1):1-4. Review.

PMID:
12485614
21.

H11 kinase is a novel mediator of myocardial hypertrophy in vivo.

Depre C, Hase M, Gaussin V, Zajac A, Wang L, Hittinger L, Ghaleh B, Yu X, Kudej RK, Wagner T, Sadoshima J, Vatner SF.

Circ Res. 2002 Nov 29;91(11):1007-14.

PMID:
12456486
22.

Quaking is essential for blood vessel development.

Noveroske JK, Lai L, Gaussin V, Northrop JL, Nakamura H, Hirschi KK, Justice MJ.

Genesis. 2002 Mar;32(3):218-30.

PMID:
11892011
23.

Endocardial cushion and myocardial defects after cardiac myocyte-specific conditional deletion of the bone morphogenetic protein receptor ALK3.

Gaussin V, Van de Putte T, Mishina Y, Hanks MC, Zwijsen A, Huylebroeck D, Behringer RR, Schneider MD.

Proc Natl Acad Sci U S A. 2002 Mar 5;99(5):2878-83. Epub 2002 Feb 19.

24.

Gene program for cardiac cell survival induced by transient ischemia in conscious pigs.

Depre C, Tomlinson JE, Kudej RK, Gaussin V, Thompson E, Kim SJ, Vatner DE, Topper JN, Vatner SF.

Proc Natl Acad Sci U S A. 2001 Jul 31;98(16):9336-41.

25.

Inducible gene targeting in postnatal myocardium by cardiac-specific expression of a hormone-activated Cre fusion protein.

Minamino T, Gaussin V, DeMayo FJ, Schneider MD.

Circ Res. 2001 Mar 30;88(6):587-92.

PMID:
11282892
26.

TAK1 is activated in the myocardium after pressure overload and is sufficient to provoke heart failure in transgenic mice.

Zhang D, Gaussin V, Taffet GE, Belaguli NS, Yamada M, Schwartz RJ, Michael LH, Overbeek PA, Schneider MD.

Nat Med. 2000 May;6(5):556-63.

PMID:
10802712
27.

Surviving infarction one gene at a time: decreased remodeling and mortality in engineered mice lacking the angiotensin II type 1A receptor.

Gaussin V, Schneider MD.

Circulation. 1999 Nov 16;100(20):2043-4. No abstract available.

PMID:
10562257
28.

Inhibition of myocardial glucose uptake by cGMP.

Depre C, Gaussin V, Ponchaut S, Fischer Y, Vanoverschelde JL, Hue L.

Am J Physiol. 1998 May;274(5):H1443-9. doi: 10.1152/ajpheart.1998.274.5.H1443.

PMID:
9612348
29.
30.

Distinct type-2A protein phosphatases activate HMGCoA reductase and acetyl-CoA carboxylase in liver.

Gaussin V, Skarlas P, Ching YP, Hardie DG, Hue L.

FEBS Lett. 1997 Aug 11;413(1):115-8.

31.

Activation of hepatic acetyl-CoA carboxylase by glutamate and Mg2+ is mediated by protein phosphatase-2A.

Gaussin V, Hue L, Stalmans W, Bollen M.

Biochem J. 1996 May 15;316 ( Pt 1):217-24.

32.

Mechanism of activation of liver acetyl-CoA carboxylase by cell swelling.

Baquet A, Gaussin V, Bollen M, Stalmans W, Hue L.

Eur J Biochem. 1993 Nov 1;217(3):1083-9.

33.

Supplemental Content

Loading ...
Support Center